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Protocol
AbstrAct
Background Asthma is a common, heterogeneous 
disease with significant morbidity and mortality worldwide. 
It can be difficult to define in epidemiological studies using 
electronic health records as the diagnosis is based on 
non-specific respiratory symptoms and spirometry, neither 
of which are routinely registered. Electronic health records 
can nonetheless be valuable to study the epidemiology, 
management, healthcare use and control of asthma. For 
health databases to be useful sources of information, 
asthma diagnoses should ideally be validated. The primary 
objectives are to provide an overview of the methods used 
to validate asthma diagnoses in electronic health records 
and summarise the results of the validation studies.
Methods EMBASE and MEDLINE will be systematically 
searched for appropriate search terms. The searches 
will cover all studies in these databases up to October 
2016 with no start date and will yield studies that have 
validated algorithms or codes for the diagnosis of asthma 
in electronic health records. At least one test validation 
measure (sensitivity, specificity, positive predictive value, 
negative predictive value or other) is necessary for 
inclusion. In addition, we require the validated algorithms 
to be compared with an external golden standard, such 
as a manual review, a questionnaire or an independent 
second database. We will summarise key data including 
author, year of publication, country, time period, date, data 
source, population, case characteristics, clinical events, 
algorithms, gold standard and validation statistics in a 
uniform table.
Ethics and dissemination This study is a synthesis of 
previously published studies and, therefore, no ethical 
approval is required. The results will be submitted to a 
peer-reviewed journal for publication. Results from this 
systematic review can be used to study outcome research 
on asthma and can be used to identify case definitions for 
asthma.
PROSPERO registration number CRD42016041798.
Background
Asthma is a common chronic inflamma-
tory disease of the airways. This condition is 
characterised by a variable expiratory airflow 
limitation which is generally reversible. The 
core symptoms are cough, wheeze, breathless-
ness and chest tightness.1 Asthma episodes 
can range from mild attacks, which interrupt 
daily life and work productivity, to severe and 
life-threatening attacks.2 Asthma is inherently 
variable and individuals will experience fluc-
tuating symptoms. Most commonly, asthma 
emerges in childhood, but it can also arise in 
adulthood. Therefore, adult asthma consists 
of both persistent or relapsed childhood 
disease and true incident adult disease. There 
is no cure, but with the right treatment, symp-
toms can usually be managed and patients 
with asthma can lead their lives without 
disruption.1
The widespread adoption of electronic 
health records (EHRs) means that large 
population-based primary and secondary 
care databases are available, proving a great 
opportunity for research on asthma and 
other diseases. The availability of routinely 
generated longitudinal records for research 
has dramatically increased over the last 
Strengths and limitations of this study
 ► To our knowledge, this is the first systematic review 
to identify and evaluate methods used to validate a 
recording of asthma diagnosis in electronic health 
records.
 ► The review of validation of asthma diagnosis in 
electronic health records could inform selection 
of asthma identification algorithms used by future 
health outcome studies and identify any gaps 
in quality and scope of validation studies. It will 
also provide an overview of the algorithms with 
their positive predictive value, negative predictive 
value, sensitivity or specificity.
 ► Different databases may validate different 
algorithms to identify asthma, which might limit 
the generalisability of these algorithms as they are 
context-specific.
 ► This review is focused on the methodology of asthma 
recording validation, and not on all outcome results 
of studies (except the validation results). Because 
of this, publication bias might be an issue (methods 
that do not find positive results may be less likely to 
have been published).
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decades.3 However, the primary function of EHRs is to 
support healthcare clinical decision-making, not research 
purposes. The integrity of the research generated from 
EHRs may be questionable, unless data are thoroughly 
validated for this purpose.4–7
EHRs are a digital reflection of the paper medical 
chart, while the main purpose of administrative claims 
data is administration of reimbursements to healthcare 
providers for their services. This systematic review will only 
consider data from EHR as the quality measures between 
the two types of data can be markedly different.8 9
EHRs store information about diagnoses as clin-
ical codes. A single code, or an algorithm consisting of 
multiple codes, can be used to retrieve records from 
EHR, and additional restrictions can be applied such as 
age or exclusion of other diseases.7 10 Alternatively, several 
authors have recently used natural language processing 
and machine learning techniques to automate algorithm 
generation for the identification of asthma diagnoses 
from large databases.11–13 The most common method to 
assess the validity of algorithms is to compare them with a 
gold standard such as another linkable data set or request 
a verification from the treating physician or the patient 
via a questionnaire.10 Another approach is active case 
detection where the databases are constantly screened to 
identify cases that emerge.14
Several limitations apply to the validation of diagnosis 
recording in EHR. First, individual databases often 
only cover a single-care setting (primary or secondary 
care) as such case ascertainment only relies on a partial 
description of the healthcare pathway.15 Another issue 
is that the validity of different diseases will not neces-
sarily be the same in a given data set. For example, 
mental health disorders such as anxiety or depression 
might be coded using less specific symptoms, whereas 
the validity of diagnoses with a very high specificity such 
as breast cancer is likely to be superior. There have 
been multiple studies which have measured the validity 
of specific databases for asthma.16 17 Sharifi et al have 
conducted a systematic review on validated methods to 
Figure 1 Study screening process: Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram from 
Moher et al.
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capture acute bronchospasm using administrative or 
claims data,18 which yielded two validation studies of 
bronchospasm codes.11 19
This systematic literature review aims to provide 
an overview of methods used to validate asthma diag-
noses, specifically in EHR. Such a study has not yet been 
published in the medical literature to the best of our 
knowledge.
research question
The primary objectives of this systematic review are to 
provide an overview of both the methods with which 
asthma diagnosis recording has been validated in EHR 
and the estimates of the validation test measures.
The questions of interest for this systematic review are
1. Which EHRs that are not only based on claims 
data have been used to obtain information on the 
diagnosis of asthma?
2. Which algorithms have been used to define an 
asthma diagnosis (including diagnostic codes, 
possible spirometry tests and clinical descriptions)?
3. How were the diagnostic criteria applied to the data 
sources and which other approaches have been 
used to validate a case definition?
4. What are the estimates for the positive predictive 
value, negative predictive value, specificity and 
sensitivity for a diagnosis of asthma in EHRs that 
are not solely claims-based?
MeThods
MEDLINE and EMBASE will be searched for the 
terms ‘asthma’, ‘validation’, ‘electronic databases’ and 
synonyms for each of these terms. In addition, refer-
ence lists of review articles and retrieved articles will be 
reviewed. The Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses flow diagram of this protocol, 
from Moher et al,20 can be found in figure 1, and the 
search strategy can be found in the online supplemen-
tary file.
Inclusion criteria
Any type of observational study design that used EHR 
to validate the recording of an asthma diagnosis will be 
considered. Articles will only be considered if published 
in English and before October 2016 without any specific 
start date. Within the databases, we will consider asthma 
diagnoses based on both structured data (such as labora-
tory results and prescriptions) and free text data (such as 
spirometry results). We require the validated algorithms 
to be compared with an external gold standard, such as a 
manual review, questionnaires (completed by the patient 
or their physician) or an independent second database. 
We will include algorithms formed of single codes, those 
requiring multiple case characteristics and algorithms 
generated by natural language processing or machine-
learning.
exclusion criteria
Studies which involve pharmacovigilance databases 
(signal detection or spontaneous reporting), studies 
without validation process of asthma recording and 
conference abstracts will be excluded. Algorithms used 
in databases originating from only claims data will also 
be excluded as a systematic review on the validated 
methods to capture acute bronchospasm using claims 
data has been published recently.18
Two independent authors will scan the abstracts and 
titles against the research questions and exclusion 
criteria and select articles for full-text review. After this 
full-text article review, eligibility for inclusion in the 
report will be decided by consensus or arbitration by a 
third reviewer. A uniform table with information of each 
included study will be populated after data extraction, 
which will include information on the author, date of 
publication, journal, database, algorithms, population, 
gold standard and test measure(s).
data synthesis
Studies and study data will be managed using EndNote 
and Microsoft Excel, respectively. The methods for 
asthma recording validation will be summarised in a 
narrative synthesis and tables describing all identified 
verification processes, and their results. These results 
will consist of the recorded PPV, NPV, sensitivity and 
specificity of the included studies. Where possible, 
these tests will be calculated if they are not reported 
within the study.
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